Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0E2BI
|
|||
| Former ID |
DNC010433
|
|||
| Drug Name |
2-fluorophenyl 4'-ethylbiphenyl-4-ylcarbamate
|
|||
| Synonyms |
CHEMBL599180; BDBM50309731; 2-fluorophenyl 4''-ethylbiphenyl-4-ylcarbamate
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H18FNO2
|
|||
| Canonical SMILES |
CCC1=CC=C(C=C1)C2=CC=C(C=C2)NC(=O)OC3=CC=CC=C3F
|
|||
| InChI |
1S/C21H18FNO2/c1-2-15-7-9-16(10-8-15)17-11-13-18(14-12-17)23-21(24)25-20-6-4-3-5-19(20)22/h3-14H,2H2,1H3,(H,23,24)
|
|||
| InChIKey |
XHWBLLJZJZYEES-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.